We are live on ! Find out more
OSRHW

OSR Health Warrant
OSRHW

31 hedge funds and large institutions have $5.51M invested in OSR Health Warrant in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

0% more funds holding

Funds holding: 31 → 31 (0)

2% less capital invested

Capital invested by funds: $5.6M → $5.51M (-$88.8K)

Holders
31
Holders Change
–
Holders Change %
0%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
2
Closed
5
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
+$4.14K
2
Walleye Trading
Walleye Trading
New York
+$2.33K
3
SIA
Schechter Investment Advisors
Michigan
+$1.14K
4
CS
Clear Street
New York
+$910
5
SIA
SkyView Investment Advisors
New Jersey
+$738

Top Sellers

Rank Fund Capital Flow
1
ASM
ATW SPAC Management
New York
-$7.65K
2
SOA
Sea Otter Advisors
Florida
-$5.73K
3
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$4.75K
4
BI
Bulldog Investors
New Jersey
-$759
5
RCM
Radcliffe Capital Management
Pennsylvania
-$180
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$3.27M – – –
MP
2
Mangrove Partners
Connecticut
$2.14M – – –
PC
3
Periscope Capital
Ontario, Canada
$18.2K – – –
HCM
4
Highbridge Capital Management
New York
$14.4K – – –
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$7.16K – – –
SCM
6
Shaolin Capital Management
Florida
$5.97K – – –
JP Morgan Chase
7
JP Morgan Chase
New York
$5.76K – – –
RCM
8
Rivernorth Capital Management
Florida
$5K – – –
SCM
9
Saba Capital Management
New York
$4.97K – – –
ETH
10
Exos TFP Holdings
New York
$4K – – –
KPF
11
K2 Principal Fund
Ontario, Canada
$3.94K -$59 -2,407 -1%
SFM
12
Spartan Fund Management
Canada
$3.84K – – –
Walleye Capital
13
Walleye Capital
New York
$3.35K +$4.14K +168,128 New
CH
14
CVI Holdings
Delaware
$3K – – –
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$2.88K – – –
RCM
16
Radcliffe Capital Management
Pennsylvania
$2.53K -$180 -7,306 -5%
WAM
17
Wolverine Asset Management
Illinois
$2.42K – – –
CS
18
Clear Street
New York
$2.35K +$910 +36,988 +46%
CC
19
Centiva Capital
New York
$2K – – –
AA
20
AQR Arbitrage
Connecticut
$1.92K – – –
Walleye Trading
21
Walleye Trading
New York
$1.88K +$2.33K +94,572 New
CAC
22
Cowen and Company
New York
$1.71K – – –
AC
23
Aristeia Capital
Connecticut
$1.33K – – –
MTCM
24
Mint Tower Capital Management
Netherlands
$1K – – –
SIA
25
Schechter Investment Advisors
Michigan
$925 +$1.14K +46,500 New
1
2

OSRHW Hedge Fund Activity: Q4 2023 in Review

31 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in OSR Health Warrant (OSRHW) for Q4 2023, worth a combined $5.51M — down 1.6% from $5.6M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new OSRHW positions and 5 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Walleye Capital, opening a new position worth an estimated $4.14K. The largest seller was ATW SPAC Management, exiting entirely with an estimated $7.65K sold.

  • 31 institutional investors held OSR Health Warrant (OSRHW) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $5.51M of OSR Health Warrant stock for Q4 2023, down 1.6% quarter-over-quarter.
  • 6 funds opened new OSR Health Warrant positions in Q4 2023 and 5 closed out, a net change of +1 holder.
  • The largest OSR Health Warrant buyer in Q4 2023 was Walleye Capital, an estimated $4.14K added.
  • The largest OSR Health Warrant seller in Q4 2023 was ATW SPAC Management, an estimated $7.65K sold.

Based on aggregated 13F filings for Q4 2023.